2014
DOI: 10.1016/j.jpedp.2014.05.007
|View full text |Cite
|
Sign up to set email alerts
|

What is new in genetics and osteogenesis imperfecta classification?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
6
0
2

Year Published

2015
2015
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 33 publications
1
6
0
2
Order By: Relevance
“…The COL1A1 and COL1A2 genes encode the two alpha chains (alpha 1 and alpha 2, respectively) of collagen type 1 that trimerize to form the procollagen 1 molecule, 29 the main component of bone matrix. Μutations in these genes account for approximately 90% of osteogenesis imperfecta (oI), which is a form of inherited osteoporosis in children characterized by low bone mass, fragile bone with increased fracture risk, blue sclerae, and in some cases impaired odontogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…The COL1A1 and COL1A2 genes encode the two alpha chains (alpha 1 and alpha 2, respectively) of collagen type 1 that trimerize to form the procollagen 1 molecule, 29 the main component of bone matrix. Μutations in these genes account for approximately 90% of osteogenesis imperfecta (oI), which is a form of inherited osteoporosis in children characterized by low bone mass, fragile bone with increased fracture risk, blue sclerae, and in some cases impaired odontogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…16) However, with an increase in newly identified causative genes, OI is now shown to be a highly divergent disease with different inheritance patterns, variable severities and multifaceted clinical conditions, and thus Sillence's classification has been repeatedly revised. In parallel, genetics-based OI classifications were proposed, 17,18) but it became impossible to maintain pathological correlations between Sillence's types and OI-responsible genes, as shown in Table 1. To avoid confusing implications in clinical practice, in 2009 the International Society of Skeletal Dysplasias released a standard classification, in which Sillence's typing is maintained as the prototypical form.…”
Section: Osteogenesis Imperfecta (Oi)mentioning
confidence: 99%
“…The incidence of the different types of OI is approximately 1/15.000-20.000 births and most cases are due to autosomal dominant inheritance with mutations in collagen, type 1 alpha-1, type 1 alpha-2 (COL1A1 or COL1A2) genes, which encode the alpha 1 and alpha 2 chains of type 1 collagen (51). Mutations in COL1A1 and COL1A2 genes altering the structure or the amount of type 1 collagen, result in a skeletal phenotype that ranges from subclinical to lethal (51). Furthermore, there are several mutant noncollagen genes causing the 5-10% of recessive cases, such as CRTAP, LEPRE1, PPIB, PLOD2, FKBP10, SERPIN H1, SERPIN F1, BMP1, IFITM5 genes.…”
Section: Metabolic Bone Diseasementioning
confidence: 99%